Colorectal Cancer Screening Rates Improve with Home Testing Kits
Colorectal cancer screening, while highly effective, is underutilized among patients at federally qualified health centers (FQHCs).
Read MorePosted by Chris Wolski | Nov 26, 2024 | Colorectal |
Colorectal cancer screening, while highly effective, is underutilized among patients at federally qualified health centers (FQHCs).
Read MorePosted by Andy Lundin | Nov 25, 2024 | Dementias & Alzheimer’s |
Researchers explored how combining CSF analysis and amyloid PET imaging can improve the accuracy and efficiency of Alzheimer’s diagnosis.
Read MorePosted by Andy Lundin | Nov 25, 2024 | Unknown Origin & Other Cancer Types |
The PATHWAY HER2 test is a CDx for HER2-positive biliary tract cancer for targeted treatment with Jazz Pharmaceuticals’ ZIIHERA.
Read MorePosted by Andy Lundin | Nov 25, 2024 | Company News |
The CLIA-certified lab launched a pharmacogenetic assay to empower tailored treatments for psychiatric, neurological, and related conditions.
Read MorePosted by Andy Lundin | Nov 22, 2024 | Pancreatic |
Researchers are leveraging AI to enhance the early detection and treatment of pancreatic cancer, focusing on identifying high-risk cysts.
Read More